Cost Of Revenue - Apollo Medical Holdings Inc (NASDAQ:ASTH) - Alpha Spread

Apollo Medical Holdings Inc
NASDAQ:ASTH

Watchlist Manager
Apollo Medical Holdings Inc Logo
Apollo Medical Holdings Inc
NASDAQ:ASTH
Watchlist
Price: 57 USD -1.45% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Apollo Medical Holdings Inc?
Write Note

Apollo Medical Holdings Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Apollo Medical Holdings Inc
Cost of Revenue Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Apollo Medical Holdings Inc
NASDAQ:ASTH
Cost of Revenue
-$1.2B
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Cost of Revenue
-$8.4B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Cost of Revenue
-$6.3B
CAGR 3-Years
2%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
CVS Health Corp
NYSE:CVS
Cost of Revenue
-$309.9B
CAGR 3-Years
-23%
CAGR 5-Years
-15%
CAGR 10-Years
-11%
Cigna Corp
NYSE:CI
Cost of Revenue
-$192B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Cost of Revenue
-$9B
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
-9%

See Also

What is Apollo Medical Holdings Inc's Cost of Revenue?
Cost of Revenue
-1.2B USD

Based on the financial report for Dec 31, 2023, Apollo Medical Holdings Inc's Cost of Revenue amounts to -1.2B USD.

What is Apollo Medical Holdings Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-30%

Over the last year, the Cost of Revenue growth was -24%. The average annual Cost of Revenue growth rates for Apollo Medical Holdings Inc have been -30% over the past three years .

Back to Top